冻融胚胎移植与新鲜胚胎移植后出生儿童的发育:一项随机对照试验的随访研究
本研究对一项比较冻融胚胎移植与新鲜胚胎移植策略的随机对照试验中活产婴儿进行长期随访,在儿童平均37月龄时用ASQ-3问卷评估发育。冻融组问题解决评分显著优于新鲜组,精细运动评分数值较高但未达统计学显著,两组异常ASQ-3和异常Red Flags比例均低且无显著差异。作者认为冻融策略未见不良结局迹象,但需进一步研究方可下确定结论。
要点
- 冻融组与新鲜组儿童身高、体重相似。
- 冻融组ASQ-3问题解决评分显著优于新鲜组。
- 两组异常ASQ-3和异常Red Flags比例均低且无显著差异。
核心结论
- 这些数据为医生权衡不同不孕治疗方案的相对优劣提供了额外信息。
- 似乎没有理由担心冻融策略后会出现更差的结局。
- 但在得出确定结论之前,仍需开展更多比较冻融策略、新鲜胚胎移植和自然周期后儿童期发育的研究。
研究设计与样本
- 研究为一项随机对照试验(NCT02471573)中首次胚胎移植后活产婴儿的长期随访研究(NCT04099784)。
- 随机对照试验将391对夫妇随机分入每个治疗组,冻融组132例(97例单胎/35例双胎)和新鲜组123例(95例单胎/28例双胎)活产。
- 本随访研究中,冻融组113名父母(86%)返回问卷(147名婴儿),新鲜组99名父母(80%)返回问卷(120名婴儿)。
- 干预为控制性卵巢过度刺激采用卵泡刺激素/促性腺激素释放拮抗剂方案后,采用冻融或新鲜胚胎移植策略。
- 研究在私立诊所开展,随访至出生后≥2年,儿童随访结束时平均年龄37个月。
主要发现
- 冻融组与新鲜组儿童身高分别为95.0 ± 6.1 cm与95.7 ± 5.6 cm,体重分别为14.9 ± 2.6 kg与14.8 ± 2.6 kg,两组相似;单独分析单胎和双胎时结果相似。
- 总体ASQ-3问题解决评分冻融组显著优于新鲜组(53.6 ± 8.4 vs. 51.1 ± 10.2),但单独分析单胎(52.3 ± 10.1 vs. 51.0 ± 9.9)和双胎(55.0 ± 5.5 vs. 51.4 ± 11.1)时组间无显著差异。
- 精细运动评分冻融组数值上高于新鲜组,总体分析(47.8 ± 11.6 vs. 44.9 ± 12.6)和双胎(49.85 ± 8.72 vs. 43.93 ± 12.71)中P值接近统计学显著,单胎(46.0 ± 13.4 vs. 45.4 ± 12.6)则无。
- 冻融组与新鲜组异常ASQ-3比例分别为6.8%与8.3%,异常Red Flags比例分别为5.4%与6.7%,均低且组间无显著差异。
临床怎么用
- 作者认为这些数据为医生权衡不同不孕治疗方案的相对优劣提供了额外信息。
- 作者认为似乎没有理由担心冻融策略后会出现更差的结局。
- 作者指出在得出确定结论之前,仍需开展更多比较冻融策略、新鲜胚胎移植和自然周期后儿童期发育的研究。
局限性
- 作者指出在得出确定结论之前,仍需开展更多比较冻融策略、新鲜胚胎移植和自然周期后儿童期发育的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the longer-term development outcomes in children born after freeze-only versus fresh embryo transfer (ET) in women with an ovulatory cycle. DESIGN: Long-term follow-up study (NCT04099784) of babies born alive after the first ET in a randomized controlled trial (RCT) comparing ongoing pregnancy and live birth rates after use of a freeze-only versus fresh ET strategy (NCT02471573). SETTING: Private clinic. PATIENT(S): Of 391 couples randomized to each treatment group in the RCT, 132 (97 singleton/35 twins) and 123 (95 singleton/28 twins) in the freeze-only and fresh ET groups had live birth; 113 parents (86%) from the freeze-only group (147 babies) and 99 (80%) from the fresh ET group (120 babies) returned questionnaires for this follow-up study. INTERVENTION(S): Use of a freeze-only or fresh ET strategy after controlled ovarian hyperstimulation with a follicle-stimulating hormone/gonadotropin-releasing antagonist protocol. MAIN OUTCOME MEASURE(S): Developmental status at ≥2 years after birth, determined using the Developmental Red Flags and Ages & Stages Third Edition (ASQ-3) Questionnaires. RESULT(S): Mean age of children at the end of follow-up was 37 months. Height (95.0 ± 6.1 vs. 95.7 ± 5.6 cm) and weight (14.9 ± 2.6 vs. 14.8 ± 2.6 kg) were similar in the freeze-only and fresh ET groups (results were similar when singletons and twins were analyzed separately). Overall, ASQ-3 scores for problem solving were significantly better in the freeze-only versus fresh ET group (overall: 53.6 ± 8.4 vs. 51.1 ± 10.2), with no significant between-group difference when singletons (52.3 ± 10.1 vs. 51.0 ± 9.9) and twins (55.0 ± 5.5 vs. 51.4 ± 11.1) were analyzed separately. Fine motor skills scores were numerically higher (with P values approaching statistical significance) in the freeze-only versus fresh ET group in the overall analysis (47.8 ± 11.6 vs. 44.9 ± 12.6) and twins (49.85 ± 8.72 vs. 43.93 ± 12.71), but not singletons (46.0 ± 13.4 vs. 45.4 ± 12.6). The overall proportion of children with abnormal ASQ-3 (6.8% vs. 8.3%) or abnormal Red Flags (5.4% vs. 6.7%) findings in the freeze-only and fresh ET groups was low and did not differ significantly between groups. CONCLUSION(S): These data provide physicians with additional information on which to base decisions about the relative merits of different approaches to infertility treatment. There do not appear to be any grounds for concern about worse outcomes after use of a freeze-only strategy. However, additional studies comparing childhood development after a freeze-only strategy, fresh ET, and natural cycles are needed before firm conclusions can be drawn.
引用
- Vuong LN, Ly TT, Nguyen NA, et al. Development of children born from freeze-only versus fresh embryo transfer: follow-up of a randomized controlled trial. Fertil Steril. 2020. PMID: 32560970. doi:10.1016/j.fertnstert.2020.04.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。